AI specialist Chai Discovery raises $400m
Summary
Chai Discovery raised $400 million in a Series C round led by Index Ventures, lifting its valuation to $3.8 billion. The company will use the capital to continue developing its AI-driven molecular design platform, Chai-3. Chai says the new model improves target success rates and binding affinity and can support preclinical drug design. The company also highlighted recent collaborations with Novartis, Pfizer, and Eli Lilly as evidence of commercial traction.
Funding
Amount
$400.0M
Total raised
Date
July 15, 2026
Announcement date
Investors
Kleiner Perkins Caufield & Byers, Baillie Gifford, Battery Ventures, Sapphire Ventures, LLC, Bain Capital Ventures, Novartis Venture Fund, DIMENSION
Lead investors
Company
chaidiscovery.com
Funded company
Classifications
industries
No industries detected
applications
Software Design & Development
AskAI Classifications
Labels
Software Development
Blockchain Software
Web3 Technology
Linked Companies
Edenia
$1M to $5M